Increasing survival time decreases the cost-effectiveness of using "test & treat to eliminate HIV epidemics
Treating HIV-infected individuals reduces their viral load, consequently increasing their survival time and decreasing their infectivity.It has been proposed that universal testing and treatment (i.e., universal ``test & treat'') could lead to HIV elimination and would be extremely...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
AIMS Press
2013-07-01
|
Series: | Mathematical Biosciences and Engineering |
Subjects: | |
Online Access: | https://www.aimspress.com/article/doi/10.3934/mbe.2013.10.1673 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832590123372380160 |
---|---|
author | Bradley G. Wagner Brian J. Coburn Sally Blower |
author_facet | Bradley G. Wagner Brian J. Coburn Sally Blower |
author_sort | Bradley G. Wagner |
collection | DOAJ |
description | Treating HIV-infected individuals reduces their viral load, consequently increasing their survival time and decreasing their infectivity.It has been proposed that universal testing and treatment (i.e., universal ``test & treat'') could lead to HIV elimination and would be extremely cost-effective.It is now being debated whether to use a universal ``test and treat'' approach in the ``real-world'' as a prevention strategy to control HIV epidemics.However current modeling predictions of the impact, and cost-effectiveness, of universal ``test & treat'' strategies are based on an unrealistically short survival time for treated individuals.Here we use mathematical modeling and a longer, more realistic, survival time.We model the potential impact of a universal ``test & treat'' strategy in South Africa.Our results show that increasing the length of the survival time on treatment, although beneficial to individuals, reduces the probability of eliminating HIV and decreases the cost-effectiveness of using universal ``test & treat'' strategies.Therefore our results show that individual-level benefits and public health benefits will conflict when using ``test & treat'' strategies to reduce HIV transmission. |
format | Article |
id | doaj-art-6fd916a95b4547cc98359c50c33e60b3 |
institution | Kabale University |
issn | 1551-0018 |
language | English |
publishDate | 2013-07-01 |
publisher | AIMS Press |
record_format | Article |
series | Mathematical Biosciences and Engineering |
spelling | doaj-art-6fd916a95b4547cc98359c50c33e60b32025-01-24T02:26:34ZengAIMS PressMathematical Biosciences and Engineering1551-00182013-07-01105&61673168610.3934/mbe.2013.10.1673Increasing survival time decreases the cost-effectiveness of using "test & treat to eliminate HIV epidemicsBradley G. Wagner0Brian J. Coburn1Sally Blower2Center for Biomedical Modeling, Semel Institute of Neuroscience & Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, 10940 Wilshire Blvd, Suite 1450, Los Angeles, CA 90024Center for Biomedical Modeling, Semel Institute of Neuroscience & Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, 10940 Wilshire Blvd, Suite 1450, Los Angeles, CA 90024Center for Biomedical Modeling, Semel Institute of Neuroscience & Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, 10940 Wilshire Blvd, Suite 1450, Los Angeles, CA 90024Treating HIV-infected individuals reduces their viral load, consequently increasing their survival time and decreasing their infectivity.It has been proposed that universal testing and treatment (i.e., universal ``test & treat'') could lead to HIV elimination and would be extremely cost-effective.It is now being debated whether to use a universal ``test and treat'' approach in the ``real-world'' as a prevention strategy to control HIV epidemics.However current modeling predictions of the impact, and cost-effectiveness, of universal ``test & treat'' strategies are based on an unrealistically short survival time for treated individuals.Here we use mathematical modeling and a longer, more realistic, survival time.We model the potential impact of a universal ``test & treat'' strategy in South Africa.Our results show that increasing the length of the survival time on treatment, although beneficial to individuals, reduces the probability of eliminating HIV and decreases the cost-effectiveness of using universal ``test & treat'' strategies.Therefore our results show that individual-level benefits and public health benefits will conflict when using ``test & treat'' strategies to reduce HIV transmission.https://www.aimspress.com/article/doi/10.3934/mbe.2013.10.1673cost-effectiveness.hiv epidemicstransmission model |
spellingShingle | Bradley G. Wagner Brian J. Coburn Sally Blower Increasing survival time decreases the cost-effectiveness of using "test & treat to eliminate HIV epidemics Mathematical Biosciences and Engineering cost-effectiveness. hiv epidemics transmission model |
title | Increasing survival time decreases the cost-effectiveness of using "test & treat to eliminate HIV epidemics |
title_full | Increasing survival time decreases the cost-effectiveness of using "test & treat to eliminate HIV epidemics |
title_fullStr | Increasing survival time decreases the cost-effectiveness of using "test & treat to eliminate HIV epidemics |
title_full_unstemmed | Increasing survival time decreases the cost-effectiveness of using "test & treat to eliminate HIV epidemics |
title_short | Increasing survival time decreases the cost-effectiveness of using "test & treat to eliminate HIV epidemics |
title_sort | increasing survival time decreases the cost effectiveness of using quot test amp treat to eliminate hiv epidemics |
topic | cost-effectiveness. hiv epidemics transmission model |
url | https://www.aimspress.com/article/doi/10.3934/mbe.2013.10.1673 |
work_keys_str_mv | AT bradleygwagner increasingsurvivaltimedecreasesthecosteffectivenessofusingquottestamptreattoeliminatehivepidemics AT brianjcoburn increasingsurvivaltimedecreasesthecosteffectivenessofusingquottestamptreattoeliminatehivepidemics AT sallyblower increasingsurvivaltimedecreasesthecosteffectivenessofusingquottestamptreattoeliminatehivepidemics |